Howard M. Sandler, MD, on Prostate Cancer Highlights: An Expert Perspective

November 09, 2021 By The ASCO Post Staff

Howard M. Sandler, MD, of Cedars-Sinai Medical Center, discusses whether hypofractionation can be safely employed in the post-prostatectomy setting and the role of short-term hormone therapy in the management of intermediate-risk prostate cancer with radiotherapy.

Related Content